PNG Gerolymatos Medical S.A.
Mr. Dimitris Sakkas (President & Managing Director)
Key Therapeutic Areas and products of the PNG Gerolymatos Medical
include:
Cardiology: Dafor (amlodipine), Vassor (simvastatine), Tanatril (imidapril
hydrochloride), Corvert (ibutilide fumarate), Cardiac Status (Myoglobin
/ Troponin)
Neurology / Psychiatry: Gabitril (tiagabine), Saroten (amitriptyline),
Ticlodone (ticlopidine), Celius (citalopram)
Osteoporosis: AD3 (alphacalcidol), Tevanate 70 (alendronate)
Dermatology: Tretin (isotrentinoin), Gynosant (fluconazole), Dermizin (cetirizin
dihydrochloride), Aregen (pimecrolimus)
Gynaecology: Norlevo (levonorgestrel), Gynosant (fluconazole)
Infectious diseases: Geromycin (clarithromycin)
Therapeutic Areas to enter in the near future include Gastroenterology,
Urology, Pulmonology and Ophthalmology.
Distribution Agreements with:
Ambrilia Biopharma,
Cephalon,
Ethypharm,
Genzyme,
GlaxoSmithKline,
Helsinn,
HRA Pharma,
Immunomedics,
Nanogen,
Pfizer,
Novartis Hellas,
Sanofi Aventis,
Sanofi Pasteur Canada,
Mitsubishi Tanabe Pharma Corporation,
Teva
Contact:
pharmaceuticals@gerolymatos.gr
